Abstract
It was reported in the 1960s that opioids show various actions through specific opioid receptors in in vitro studies (Kosterlitz and Watt, 1968). In 1971 and 1973, opiate receptors were reported by several independent investigators, in a ligand binding study in brain membranes (Goldstein et al., 1971; Pert and Snyder, 1973; Simon et a1.,1973; Terenius, 1973). The study of opioid receptors was accelerated by the discovery of endogenous opioids, such as enkephalins (Hughes et al., 1975), β-endorphin, dynorphin, and their related peptides (Goldstein, 1984; Yamashiro and Li, 1984). Biochemical, pharmacological, and behavioral studies provided the evidence that various actions of opiates and opioid peptides in the brain and peripheral tissues are mediated by interactions with different subtypes of opioid receptors, such as µ-, δ-, and κ-opioid receptors (Martin et al., 1976; Lord et al., 1977). Furthermore, the discovery of selective ligands for each subtype of opioid receptor (Paterson et al., 1984) made it easy to study the receptor subtype-specific responses in vivo and in vitro. For instance, in in vivo studies, the µ-opioid receptor is thought to be closely relevant to the production of analgesia in the brain (Satoh et al., 1983; Porreca et al., 1984). On the other hand, there are accumulating findings in vitro that µ- and δ- receptors are functionally coupled to the stimulation of potassium ion channel activity (North et al., 1987), whereas κ-receptor indicates an inhi-bition of calcium ion channel activity (Gross and Macdonald, 1987). In addition, µ-and δ-receptors are functionally coupled to the inhibition of adenylate cyclase in membranes of the brain and NG108-15 cells (Collier and Roy, 1974; Klee and Nirenberg, 1976).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Burgoyne, R. D. (1983) J. Neurochem. 40, 324–331.
Burns, D., Hewlett, E. L., Moss, J., and Vaughan, M. (1983) J. Biol. Chem. 258,1435–1438.
Cerione, R. A., Regan, J. W., Nakata, H., Codina, J., Benovic, J. L., Gierschik, P., Somers,R., Spiegel, A. M., Birnbaumer, L., and Lefkowitz, R. J. (1986) J. Biol. Chem. 261,3901–3909.
Cho, T. M., Hasegawa, J., Ge, B., and Loh, H. H. (1986) Proc. Natl. Acad. Sci. USA 83,4138–4142.
Collier, H. O. J. and Roy, A. C. (1974) Nature (London) 248, 24–27.
Fujioka, T., Inoue, F., and Kuriyama, M. (1985) Biochem. Biophys. Res. Comm. 131,640–646.
Gilman, A. G. (1987) Ann. Rev. Biochem. 56, 615–649.
Gioannini, T. L., Howard, A. D., Hiller, J. M., and Simon, E. J. (1985) J. Biol. Chem. 260, 15117–15121.
Goldstein, A. (1984) in The Peptides, vol. 6 (Udenfriend, S. and Meienhofer, J., eds.), Academic, Orlando, FL, pp. 95–145.
Goldstein, A., Lowney, L. I., and Pal, B. K. (1971) Proc. Natl. Acad. Sci. USA 68,1742–1747.
Gross, R. A. and Macdonald, R. L. (1987) Proc. Natl. Acad. Sci. USA 84,5469–5473.
Hara, M., Tamaoki, T., and Nakamura, H. (1988) Oncogene Res. 2,325–333.
Harada, M., Ueda, M., Wada, Y., Katada, T., Ui, M., and Satoh, M. (1989) Neurosci. Lett. 100,221–226.
Ho, A. K. S., Ling, Q.-L., Duffield, R., Lam, P. H., and Wang, J. H. (1987) Biochem. Biophys. Res. Comm. 142,911–918.
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., and Morris, H. R. (1975) Nature (London) 258, 577–579.
Itoh, H., Toyama, R., Kozasa, T., Tsukamoto, T., Matsuoka, M., and Kaziro, Y. (1988)J. Biol. Chem. 263,6656–6664.
Katada, T., Oinuma, M., Kusakabe, K., and Ui, M. (1987) FEBS Lett. 213, 353–358.
Katada, T., Oinuma, M., and Ui, M. (1986) J. Biol. Chem. 261, 8182–8191.
Kelleher, D. J., Pessin, J. E., Ruoho, A. E., and Johnson, G. L. (1984) Proc. Natl. Acad. Sci. USA 81, 4316–4320.
Klee, W. A. and Nirenberg, M. (1976) Nature (London) 163,609–612.
Kosterlitz, H. W. and Watt, A. J. (1968) Br. J. Pharmacol. 33,266–276.
Kurose, H., Katada, T., Amano, T., and Ui, M. (1983) J. Biol. Chem. 258,4870–4875.
Kurose, H., Katada, T., Haga, T., Haga, K., Ichiyama, A., and Ui, M. (1986) J. Biol. Chem. 261, 6423–6428.
Kurose, H. and Ui, M. (1985) Arch. Biochem. Biophys. 238,424–434.
Lord, J. A. H., Waterfield, A. A., Hughes, J., and Kosterlitz, H. W. (1977) Nature (London) 267, 495–499.
Lowney, L. I., Schulz, K., Lowery, P., and Goldstein, A. (1974) Science 183, 749–753.
Maneckjee, R., Zukin, R. S., Archer, S., Michael, J., and Osei-Gyimah, P. (1985) Proc. Natl. Acad. Sci. USA 82,594–598.
Martin, W. R., Eades, C. G., Thompson, J. A., Huppher, R. E., and Gilbert, P. E. (1976) J. Pharmacol. Exp. Then. 197, 517–532.
Matozaki, T., Sakamoto, C., Nagao, M., and Baba, S. (1986) J. Biol. Chem. 261,1414–1420.
Neer, E. J. and Clapham, D. E. (1988) Nature (London) 333,129–134.
North, A., Williams, J. T., Surprenant, A., and Christie, M. J. (1987) Proc. Natl. Acad. Sci. USA 84, 5487–5491.
Paterson, S. J., Robson, L. E., and Kosterlitz, H. W. (1984) in The Peptides, vol. 6 (Udenfriend, S. and Meienhofer, J., eds.), Academic, Orlando, FL, pp. 147–189.
Pedersen, S. E. and Ross, E. M. (1982) Proc. Natl. Acad. Sci. 79, 7228–7232.
Pert, C. B. and Snyder, S. H. (1973) Science 179,1011–1014.
Porreca, F., Mosberg, H. I., Hurst, R., Hruby, V. J., and Burks, T. F. (1984) J. Pharmacol. Exp. Ther. 230, 341–348.
Satoh, M., Kubota, A., Iwama, T., Yasui, M., Fujibayashi, K., and Takagi, H. (1983) Life Sci. 33 (suppl. I), 689–692.
Sibley, D. R. and Lefkowitz, R. J. (1985) Nature (London) 317,124–129.
Simon, E. J., Hiller, J. M., and Edelman, I. (1973) Proc. Natl. Acad. Sci. USA 70,1947–1949.
Simon, E. J., Hiller, J. M., and Edelman, I. (1975) Science 190, 389–390.
Simonds, W. F., Burke, T. R., Rice, K. C., Jacobson, A. E., and Klee, W. A. (1985) Proc. Natl. Acad. Sci. USA 82,4974–4978.
Terenius, L. (1973) Acta Pharmacol. Toxicol. 33,377–384.
Ueda, H., Harada, H., Nozaki, M., Katada, T., Ui, M., Satoh, M., and Takagi, H. (1988a) Proc. Natl. Acad. Sci. USA 85, 7013–7017.
Ueda, H., Harada, H., Misawa, H., Nozaki, M., and Takagi, H. (1987a) Neurosci. Lett. 75, 339–344.
Ueda, H., Harada, H., Wada, Y., Katada, T., Ui, M., Takagi, H., and Satoh, M. (1988b) Abstracts of 18th Annual Meeting of Society for Neuroscience,Toronto, p. 1053.
Ueda, H., Misawa, H., Fukushima, N., and Takagi, H. (1987b) Eur. J. Pharmacol. 138, 129–132.
Ueda, H., Misawa, H., Katada, T., Ui, M., Takagi, H., and Satoh, M. (1989) in Advances in the Biosciences (Cros, J., Meunier, J.-C., and Hamon, M., eds.), Pergamon Press, Great Britain, pp. 129–132.
Ueda, H., Misawa, H., Katada, T., Ui, M., Takagi, H., and Satoh, M. (1990) J. Neurochem., in press.
Ueda, H. and Satoh, M. (1988) in Advances in Endocrinology (Imura, H., ed.), Elsevier, Netherlands, pp. 1137–1142.
Ui, M. (1984) Trends Pharmacol. Sci. 5, 277–279.
Yamashiro, D. and Li, C. H. (1984) in The Peptides, vol. 6 (Udenfriend, S. and Meienhofer, J., eds.), Academic, Orlando, FL pp. 191–217.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ueda, H., Satoh, M. (1990). µ-Opioid Receptor. In: Litwack, G. (eds) Receptor Purification. Receptor Purification, vol 1. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0461-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0461-9_6
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6771-3
Online ISBN: 978-1-4612-0461-9
eBook Packages: Springer Book Archive